Postoperative Therapy After Interposition Arthroplasty in CMC1
NCT ID: NCT01679717
Last Updated: 2015-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2012-06-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short-term Recovery After Trapeziectomy and TMC Prosthesis: a Diary Study
NCT06654349
Trapeziometacarpal Prosthesis vs. Resection-Interposition Arthroplasty
NCT05267964
Post-operative Results of the Trapezometacarpal (TMC) Prosthesis for Advanced Pre-operative Deformities
NCT05169099
Group Exercise After Hip Replacement Surgery
NCT01253798
Comparison of Stemless and Stemmed Shoulder Arthroplasty for Osteoarthritis
NCT04105478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early mobilisation after CMC1-surgery
Mobilisation at two weeks after operation. The participants will wear a soft splint for six weeks.
Early mobilisation after CMC1-surgery
Comparison of early (two weeks) and conservative (six weeks) mobilisation after operation. Comparison of rigid and soft thumb splint.
Conservative treatment after CMC1-surgery
Current standard procedure: Mobilisation at six weeks after operation. The participants will wear a rigid splint for six weeks.
Early mobilisation after CMC1-surgery
Comparison of early (two weeks) and conservative (six weeks) mobilisation after operation. Comparison of rigid and soft thumb splint.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early mobilisation after CMC1-surgery
Comparison of early (two weeks) and conservative (six weeks) mobilisation after operation. Comparison of rigid and soft thumb splint.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Planned surgery(interposition arthroplasty) in CMC1
* Ability to communicate in Norwegian
Exclusion Criteria
* Previous surgery of the same thumb.
* Other diseases og injuries that could influence hand function.
* Mental or cognitive deficit.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Norwegian Women´s Public Health Association
OTHER
Diakonhjemmet Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tove Nilsen
Occupational therapist MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ingvild Kjeken, Ph.d
Role: STUDY_CHAIR
Department of Rheumatology, Diakonhjemmet hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diakonhjemmet hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H4/2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.